Literature DB >> 35231129

The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.

Ali Zarezadeh Mehrabadi1,2, Nazanin Aghamohamadi1,2, Majid Khoshmirsafa1,2, Azin Aghamajidi1,2, Mohammad Pilehforoshha3, Ramin Massoumi4, Reza Falak1,2.   

Abstract

Interleukin-1 receptor accessory protein (IL-1RAcP) is a member of the immunoglobulin superfamily proteins consisting of soluble and membranous isoforms. IL-1RAcP plays an essential role in the signaling of the IL-1 family cytokines such as IL-1, IL-33 and IL-36, as well as tyrosine kinases FLT3 and C-Kit. IL-1RAcP generally initiates inflammatory signaling pathway through the recruitment of signaling mediators, including MYD88 and IRAK. Chronic inflammation following prolonged signaling of cytokine receptors is a critical process in the pathogenesis of many inflammatory disorders, including autoimmunity, obesity, psoriasis, type 1 diabetes, endometriosis, preeclampsia and Alzheimer's disease. Recently IL-1RAcP aberrant signaling has been considered to play a central role in the pathogenesis of these chronic inflammatory diseases. Targeting IL-1RAcP signaling pathway that was recently considered in clinical trials related to malignancies also indicates its potential as therapeutic target for the inflammatory and autoimmune diseases. This review summarizes the molecular structure, components associated with IL-1RAcP signaling pathways, and their involvement in the pathogenesis of different inflammatory diseases. We will also discuss the effect of IL-1RAcP inhibition for treatment proposes.
© 2022 John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-1; IL-1 receptor accessory protein; Inflammation

Mesh:

Substances:

Year:  2022        PMID: 35231129     DOI: 10.1111/imm.13462

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  3 in total

Review 1.  The Controversial Role of IL-33 in Lung Cancer.

Authors:  Keshan Yang; Cheng Tian; Chengliang Zhang; Ming Xiang
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

2.  Exploration of the core protein network under endometriosis symptomatology using a computational approach.

Authors:  Fatima El Idrissi; Mathilde Fruchart; Karim Belarbi; Antoine Lamer; Emilie Dubois-Deruy; Mohamed Lemdani; Assi L N'Guessan; Benjamin C Guinhouya; Djamel Zitouni
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

3.  miR21 modulates the Hippo signaling pathway via interference with PP2A Bβ to inhibit trophoblast invasion and cause preeclampsia.

Authors:  Mingyu Hu; Yangxi Zheng; Jiujiang Liao; Li Wen; Juan Cheng; Jiayu Huang; Biao Huang; Li Lin; Yao Long; Yue Wu; Xuan Ye; Yong Fu; Hongbo Qi; Philip N Baker; Chao Tong
Journal:  Mol Ther Nucleic Acids       Date:  2022-09-20       Impact factor: 10.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.